Related Experiment Video

Updated: Feb 10, 2026

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
08:43

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

Published on: July 28, 2012

15.2K

Combination Treatment with Intravesical Interferon-Alpha Gene Therapy and Oral Pan-ErbB Receptor Family Blocker

Akshay Sood, Alberto Martini, Jan K Rudzinski

    Biorxiv : the Preprint Server for Biology
    |February 9, 2026
    PubMed
    Abstract

    Insights

    Combining interferon-alpha (IFNα) gene therapy with an ErbB pathway inhibitor like Afatinib significantly improves outcomes for bladder cancer. This combination therapy enhances survival and reduces tumor cell viability and migration in preclinical models.

    Area of Science:

    • Oncology
    • Gene Therapy
    • Pharmacology

    Background:

    • Intravesical interferon-alpha (IFNα) gene therapy shows promise for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC).
    • Identifying resistance mechanisms is crucial for improving IFNα gene therapy efficacy in NMIBC treatment.

    Purpose of the Study:

    • To investigate the ErbB pathway as a resistance mechanism to IFNα gene therapy in NMIBC.
    • To evaluate the efficacy of combining intravesical IFNα gene therapy with Afatinib, an ErbB pathway inhibitor, for NMIBC treatment.

    Main Methods:

    • RNA-sequencing was performed on MB49 murine tumors treated with IFNα gene therapy to identify resistance pathways.
    • MB49 cells were treated in vitro with lentiviral IFNα (LV-IFNα) and/or Afatinib, followed by cell viability and migration assays.
    • In vivo studies utilized the MB49 orthotopic murine bladder cancer model, randomizing mice into five treatment groups (saline, LV-Ctrl, Afatinib, LV-IFNα, and combination therapy) to assess overall survival and toxicity.

    Main Results:

    • Combination therapy significantly reduced MB49 cell viability in vitro (4% vs. 26-100%) and inhibited cell migration (92.3 cells vs. 270.3-631.0 cells).
    • In vivo studies showed a significant improvement in median overall survival for the combination therapy group (49 days) compared to monotherapy or control groups (15-29 days).
    • No drug toxicity-related deaths were observed in the combination therapy group.

    Conclusions:

    • The ErbB pathway is identified as a clinically significant resistance mechanism to intravesical IFNα gene therapy in NMIBC.
    • Concurrent targeting of the ErbB pathway with Afatinib alongside IFNα gene therapy demonstrates potential for improved treatment efficacy in NMIBC.

    More Related Videos

    Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

    Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

    Published on: October 6, 2022

    3.0K
    An Orthotopic Bladder Cancer Model for Gene Delivery Studies07:48

    An Orthotopic Bladder Cancer Model for Gene Delivery Studies

    Published on: December 1, 2013

    13.1K

    Related Concept Videos

    Gene Families01:57

    Gene Families

    Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
    Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
    10.0K
    Gene Families01:57

    Gene Families

    3.9K
    Family Therapy01:30

    Family Therapy

    Family therapy conceptualizes psychological challenges as arising from dysfunctional interactions within the family unit, rather than as isolated issues within individuals. This approach seeks to address and transform the patterns of communication, roles, and relationships within families to promote healthier dynamics and emotional well-being for all members.
    Strategic Family Therapy
    Strategic family therapy emphasizes resolving communication barriers and improving problem-solving abilities...
    609
    Gene Therapy00:59

    Gene Therapy

    Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
    27.7K
    Protein Families02:47

    Protein Families

    Protein families are groups of homologous proteins; that is, they have similarities in amino acid sequences and three-dimensional structures. Protein families usually occur because of gene duplication, where an additional copy of a gene is inserted into the genome of an organism.   Mutations that change the amino acids but still allow the protein to be properly synthesized, will lead to new protein family members.   If these new proteins contain similar amino acids in key...
    17.1K
    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
    774